Study of user experience of an objective test (QbTest) to aid ADHD assessment and medication management: a multi-methods approach
Tóm tắt
The diagnosis and monitoring of Attention deficit hyperactivity disorder (ADHD) typically relies on subjective reports and observations. Objective continuous performance tests (CPTs) have been incorporated into some services to support clinical decision making. However, the feasibility and acceptability of adding such a test into routine practice is unknown. The study aimed to investigate the feasibility and acceptability of adding an objective computerised test to the routine assessment and monitoring of attention deficit hyperactivity disorder (ADHD). Semi-structured interviews were conducted with clinicians (n = 10) and families (parents/young people, n = 20) who participated in a randomised controlled trial. Additionally, the same clinicians (n = 10) and families (n = 76) completed a survey assessing their experience of the QbTest. The study took place in child and adolescent mental health and community paediatric clinics across the UK. Interview transcripts were thematically analysed. Interviewed clinicians and families valued the QbTest for providing an objective, valid assessment of symptoms. The QbTest was noted to facilitate communication between clinicians, families and schools. However, whereas clinicians were more unanimous on the usefulness of the QbTest, survey findings showed that, although the majority of families found the test useful, less than half felt the QbTest helped them understand the clinician’s decision making around diagnosis and medication. The QbTest was seen as a potentially valuable tool to use early in the assessment process to streamline the care pathway. Although clinicians were conscious of the additional costs, these could be offset by reductions in time to diagnosis and the delivery of the test by a Healthcare Assistant. The findings indicate the QbTest is an acceptable and feasible tool to implement in routine clinical settings. Clinicians should be mindful to discuss the QbTest results with families to enable their understanding and engagement with the process. Further findings from definitive trials are required to understand the cost/benefit; however, the findings from this study support the feasibility and acceptability of integrating QbTest in the ADHD care pathway. The findings form the implementation component of the Assessing QbTest Utility in ADHD (AQUA) Trial which is registered with the ISRCTN registry (
ISRCTN11727351
, retrospectively registered 04 July 2016) and clinicaltrials.gov (
NCT02209116
, registered 04 August 2014).
Tài liệu tham khảo
NICE. Attention deficit hyperactivity disorder:diagnosis and managment of ADHD in children, young people and adults. Clinical Guideline 72. London: National Institute for Health and Clinical Excellence; 2008.
Hall CL, Walker GM, Valentine AZ, Guo B, Kaylor-Hughes C, James M, Daley D, Sayal K, Hollis C. Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD—‘Assessing QbTest Utility in ADHD’(AQUA): a randomised controlled trial. BMJ Open. 2014;4(12):e006838.
Hall CL, Taylor JA, Newell K, Baldwin L, Sayal K, Hollis C. The challenges of implementing ADHD clinical guidelines and research best evidence in routine clinical care settings: Delphi survey and mixed-methods study. Brit J Psychiat Open. 2016;2(1):25–31.
King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R. A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Asses. 2006; 10(23):iii-iv, xiii-146.
Hall CL, Selby K, Guo B, Valentine AZ, Walker GM, Hollis C. Innovations in Practice: an objective measure of attention, impulsivity and activity reduces time to confirm attention deficit/hyperactivity disorder diagnosis in children–a completed audit cycle. Child Adolesc Ment Health. 2016; doi:10.1111/camh.12140
Hall CL, Valentine AZ, Groom MJ, Walker GM, Sayal K, Daley D, Hollis C. The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review. Eur Child Adoles Psy. 2016;25:677–99.
Ulberstad F. QbTest technical manual. Stockholm, Sweden: Qbtech AB; 2012.
Reh V, Schmidt M, Lam L, Schimmelmann BG, Hebebrand J, Rief W, Christiansen H. Behavioral Assessment of Core ADHD Symptoms Using the QbTest. J Of Atten Disorders. 2015;19(12):1034–45.
Reh V, Schmidt M, Rief W, Christiansen H. Preliminary evidence for altered motion tracking-based hyperactivity in ADHD siblings. Behav Brain Funct. 2014;10:7.
Vogt C, Shameli A. Assessments for attention-deficit hyperactivity disorder: Use of objective measurements. Psychiatrist. 2011;35(10):380–3.
Groom MJ, Young Z, Hall CL, Gillott A, Hollis C. The incremental validity of a computerised assessment added to clinical rating scales to differentiate adult ADHD from autism spectrum disorder. Psychiat Res. 2016;243:168–73.
Wehmeier PM, Schacht A, Wolff C, Otto WR, Dittmann RW, Banaschewski T. Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device. J Child Adolesc Psychopharmacol. 2011;21:433–44.
Ramtvedt BE, Røinås E, Aabech HS, Sundet KS. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. J Child Adolesc Psychopharmacol. 2013;23(9):597–604.
Gunther T, Kahraman-Lanzerath B, Knospe EL, Herpertz-Dahlmann B, Konrad K. Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day. J Child Adolesc Psychopharmacol. 2012;22:131–8.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
Joffe H, Yardley L, Marks D. Research methods for clinical health and psychology. London: UK Sage; 2004.
Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, Heal D, Müller U, Nash J, Santosh P. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28:179–203.
Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J of Psychiat. 2002;159(1):36–42.
Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997;36(8):1036–45.
Simons L, Valentine AZ, Falconer CJ, Groom M, Daley D, Craven MP, Young Z, Hall C, Hollis C. Developing mHealth remote monitoring technology for attention deficit hyperactivity disorder: a qualitative study eliciting user priorities and needs. JMIR mHealth uHealth. 2016;4(1):e31.
Hall CL, Taylor J, Moldavsky M, Marriott M, Pass S, Newell K, Goodman R, Sayal K, Hollis C. A qualitative process evaluation of electronic session-by-session outcome measurement in child and adolescent mental health services. BMC Psychiatry. 2014;14(1):113.
Bussing R, Zima BT, Mason D, Hou W, Garvan CW, Forness S. Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2005;15(1):78–87.
Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559–67.
Chacko A. H Newcorn J, Feirsen N, Z Uderman J: Improving medication adherence in chronic pediatric health conditions: a focus on ADHD in youth. Curr Pharm Des. 2010;16(22):2416–23.
Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. Journal of the American Academy of Child & Adolescent Psychiatry. 1997;36(6):754–63.